SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-014636
Filing Date
2017-12-15
Accepted
2017-12-15 11:13:45
Documents
5
Period of Report
2017-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 25002
2 ex99-1.htm EX-99.1 31769
3 ex99-1_001.jpg GRAPHIC 4152
4 ex99-1_002.jpg GRAPHIC 35521
5 ex99-1_003.jpg GRAPHIC 46311
  Complete submission text file 0001493152-17-014636.txt   176736
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 171258058
SIC: 2836 Biological Products, (No Diagnostic Substances)